ACE Gene Polymorphism and Losartan Treatment in Type 2 Diabetic Patients With Nephropathy

Losartan treatment reduced renal outcomes in proteinuric patients with type 2 diabetes in the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) study. It is unknown whether an insertion (I)/deletion (D) polymorphism in the angiotensin I-converting enzyme (ACE) gene...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Parving, Hans-Henrik, de Zeeuw, Dick, Cooper, Mark E., Remuzzi, Giuseppe, Liu, Nancy, Lunceford, Jared, Shahinfar, Shahnaz, Wong, Peggy H., Lyle, Paulette A., Rossing, Peter, Brenner, Barry M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Nephrology 2008
Konular:
Clinical Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2390973/
https://ncbi.nlm.nih.gov/pubmed/18199798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2007050582
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller